For example, in prostate cancer, SPOP, acting as a tumor suppressor, inhibits the development of prostate cancer by degrading carcinogenic factors androgen receptor31, c-MYC32, ETS-related gene33, and Egl-9 family hypoxia-inducible factor 2 (ref. 34). This evidence concerns the gene SPOP and Familial prostate cancer.